Han Yu Pharmaceutical (300199.SZ) released its half-year performance, turning losses into profits to 1.45 billion yuan.

Choicest Financial APP News, HanYu Pharmaceuticals (300199.SZ) released its 2025 semi-annual report, with the company's operating income reaching 549 million yuan, a year-on-year increase of 114.86%. The net profit attributable to shareholders of listed companies was 145 million yuan. The net profit attributable to shareholders of listed companies after deducting non-recurring gains and losses was 123 million yuan. The basic earnings per share were 0.16 yuan.